SCHEMBL2970505

SCHEMBL2970505

C=Cc1ccc(CN2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4CC)CC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 1/20 0.67
▸ HSD17B10 Q99714 3/20 0.64
▸ KDM4E B2RXH2 8/20 0.64
▸ ALDH1A1 P00352 4/20 0.64
▸ HPGD P15428 4/20 0.64
▸ HTT P42858 4/20 0.64
▸ LMNA P02545 2/20 0.64
▸ TSHR P16473 2/20 0.64
▸ BRD4 O60885 1/20 0.64
▸ CYP2J2 P51589 1/20 0.64
▸ NPSR1 Q6W5P4 1/20 0.64
▸ KMT2A Q03164 7/20 0.62
▸ MEN1 O00255 6/20 0.62
▸ NPC1 O15118 1/20 0.62
▸ USP2 O75604 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ PIK3CG P48736 3/20 0.60
▸ PIK3CD O00329 2/20 0.60
▸ PIK3R1 P27986 2/20 0.60
▸ PIK3CA P42336 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26193832 0.91 DRD3 (0.72) DRD3HSD17B10KDM4EALDH1A1HPGD
SCHEMBL25380525 0.90 DRD3 (0.71) DRD3HSD17B10KDM4EALDH1A1HPGD
SCHEMBL30306102 0.90 DRD3 (0.71) DRD3HSD17B10KDM4EALDH1A1HPGD
SCHEMBL26193814 0.90 DRD3 (0.71) DRD3HSD17B10KDM4EALDH1A1HPGD
SCHEMBL30306107 0.90 DRD3 (0.73) DRD3HSD17B10KDM4EALDH1A1HPGD
SCHEMBL20577115 0.90 DRD3 (0.73) DRD3HSD17B10KDM4EALDH1A1HPGD
SCHEMBL11024313 0.89 DRD3 (0.69) DRD3HSD17B10KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL25378349 0.89 DRD3 (0.69) DRD3HSD17B10KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL25379465 0.89 DRD3 (0.72) DRD3HSD17B10KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL30306094 0.89 DRD3 (0.72) DRD3HSD17B10KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7777033-B2 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof MICRO SCIENCE TECH CO., LTD. (KR) 2010-08-17 — — US disclosed
US-20080188655-A1 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof MICRO SCIENCE TECH CO., LTD. (KR) 2008-08-07 — — US disclosed
US-7361719-B2 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof MICRO SCIENCE TECH CO., LTD. (KR) 2008-04-22 — — US disclosed
US-20050176905-A1 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof MICRO SCIENCE TECH CO., LTD. (KR) 2005-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188655-A1 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof PCNA, HSF1, TERB1 DRD3 1287/4885HSD17B10 2090/4885KDM4E 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback